Global Invasive Fungal Infection Market Research Report 2023
Invasive fungal infection refers to the pathological changes and pathophysiological processes of fungi that invade human tissues and blood, and grow and multiply in them, leading to tissue damage, organ dysfunction, and inflammation.
According to QYResearch’s new survey, global Invasive Fungal Infection market is projected to reach US$ 13980 million in 2029, increasing from US$ 10360 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Invasive Fungal Infection market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Invasive Fungal Infection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Invasive Fungal Infection market is projected to reach US$ 13980 million in 2029, increasing from US$ 10360 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Invasive Fungal Infection market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Invasive Fungal Infection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Cidara Therapeutics
- Basilea Pharmaceutica
- Pfizer
- GlaxoSmithKline
- Bayer
- Abbott
- Merck
- Astellas Pharma
- F2G
- Scynexis
- Associates of Cape Cod
- BioRad
- IMMY
- Beijing Jinshanchuan
- Danna Biological
- Zhanjiang A and C Biological
- Diagnosis
- Treatment
- Yeast-like Fungi
- Filamentous Fungi
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Invasive Fungal Infection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Invasive Fungal Infection Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Yeast-like Fungi
1.3.3 Filamentous Fungi
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Invasive Fungal Infection Market Perspective (2018-2029)
2.2 Invasive Fungal Infection Growth Trends by Region
2.2.1 Global Invasive Fungal Infection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Invasive Fungal Infection Historic Market Size by Region (2018-2023)
2.2.3 Invasive Fungal Infection Forecasted Market Size by Region (2024-2029)
2.3 Invasive Fungal Infection Market Dynamics
2.3.1 Invasive Fungal Infection Industry Trends
2.3.2 Invasive Fungal Infection Market Drivers
2.3.3 Invasive Fungal Infection Market Challenges
2.3.4 Invasive Fungal Infection Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Invasive Fungal Infection Players by Revenue
3.1.1 Global Top Invasive Fungal Infection Players by Revenue (2018-2023)
3.1.2 Global Invasive Fungal Infection Revenue Market Share by Players (2018-2023)
3.2 Global Invasive Fungal Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Invasive Fungal Infection Revenue
3.4 Global Invasive Fungal Infection Market Concentration Ratio
3.4.1 Global Invasive Fungal Infection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Invasive Fungal Infection Revenue in 2022
3.5 Invasive Fungal Infection Key Players Head office and Area Served
3.6 Key Players Invasive Fungal Infection Product Solution and Service
3.7 Date of Enter into Invasive Fungal Infection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 INVASIVE FUNGAL INFECTION BREAKDOWN DATA BY TYPE
4.1 Global Invasive Fungal Infection Historic Market Size by Type (2018-2023)
4.2 Global Invasive Fungal Infection Forecasted Market Size by Type (2024-2029)
5 INVASIVE FUNGAL INFECTION BREAKDOWN DATA BY APPLICATION
5.1 Global Invasive Fungal Infection Historic Market Size by Application (2018-2023)
5.2 Global Invasive Fungal Infection Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Invasive Fungal Infection Market Size (2018-2029)
6.2 North America Invasive Fungal Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Invasive Fungal Infection Market Size by Country (2018-2023)
6.4 North America Invasive Fungal Infection Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Invasive Fungal Infection Market Size (2018-2029)
7.2 Europe Invasive Fungal Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Invasive Fungal Infection Market Size by Country (2018-2023)
7.4 Europe Invasive Fungal Infection Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Invasive Fungal Infection Market Size (2018-2029)
8.2 Asia-Pacific Invasive Fungal Infection Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Invasive Fungal Infection Market Size by Region (2018-2023)
8.4 Asia-Pacific Invasive Fungal Infection Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Invasive Fungal Infection Market Size (2018-2029)
9.2 Latin America Invasive Fungal Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Invasive Fungal Infection Market Size by Country (2018-2023)
9.4 Latin America Invasive Fungal Infection Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Invasive Fungal Infection Market Size (2018-2029)
10.2 Middle East & Africa Invasive Fungal Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Invasive Fungal Infection Market Size by Country (2018-2023)
10.4 Middle East & Africa Invasive Fungal Infection Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Cidara Therapeutics
11.1.1 Cidara Therapeutics Company Detail
11.1.2 Cidara Therapeutics Business Overview
11.1.3 Cidara Therapeutics Invasive Fungal Infection Introduction
11.1.4 Cidara Therapeutics Revenue in Invasive Fungal Infection Business (2018-2023)
11.1.5 Cidara Therapeutics Recent Development
11.2 Basilea Pharmaceutica
11.2.1 Basilea Pharmaceutica Company Detail
11.2.2 Basilea Pharmaceutica Business Overview
11.2.3 Basilea Pharmaceutica Invasive Fungal Infection Introduction
11.2.4 Basilea Pharmaceutica Revenue in Invasive Fungal Infection Business (2018-2023)
11.2.5 Basilea Pharmaceutica Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Invasive Fungal Infection Introduction
11.3.4 Pfizer Revenue in Invasive Fungal Infection Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Invasive Fungal Infection Introduction
11.4.4 GlaxoSmithKline Revenue in Invasive Fungal Infection Business (2018-2023)
11.4.5 GlaxoSmithKline Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Invasive Fungal Infection Introduction
11.5.4 Bayer Revenue in Invasive Fungal Infection Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Invasive Fungal Infection Introduction
11.6.4 Abbott Revenue in Invasive Fungal Infection Business (2018-2023)
11.6.5 Abbott Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Invasive Fungal Infection Introduction
11.7.4 Merck Revenue in Invasive Fungal Infection Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Astellas Pharma
11.8.1 Astellas Pharma Company Detail
11.8.2 Astellas Pharma Business Overview
11.8.3 Astellas Pharma Invasive Fungal Infection Introduction
11.8.4 Astellas Pharma Revenue in Invasive Fungal Infection Business (2018-2023)
11.8.5 Astellas Pharma Recent Development
11.9 F2G
11.9.1 F2G Company Detail
11.9.2 F2G Business Overview
11.9.3 F2G Invasive Fungal Infection Introduction
11.9.4 F2G Revenue in Invasive Fungal Infection Business (2018-2023)
11.9.5 F2G Recent Development
11.10 Scynexis
11.10.1 Scynexis Company Detail
11.10.2 Scynexis Business Overview
11.10.3 Scynexis Invasive Fungal Infection Introduction
11.10.4 Scynexis Revenue in Invasive Fungal Infection Business (2018-2023)
11.10.5 Scynexis Recent Development
11.11 Associates of Cape Cod
11.11.1 Associates of Cape Cod Company Detail
11.11.2 Associates of Cape Cod Business Overview
11.11.3 Associates of Cape Cod Invasive Fungal Infection Introduction
11.11.4 Associates of Cape Cod Revenue in Invasive Fungal Infection Business (2018-2023)
11.11.5 Associates of Cape Cod Recent Development
11.12 BioRad
11.12.1 BioRad Company Detail
11.12.2 BioRad Business Overview
11.12.3 BioRad Invasive Fungal Infection Introduction
11.12.4 BioRad Revenue in Invasive Fungal Infection Business (2018-2023)
11.12.5 BioRad Recent Development
11.13 IMMY
11.13.1 IMMY Company Detail
11.13.2 IMMY Business Overview
11.13.3 IMMY Invasive Fungal Infection Introduction
11.13.4 IMMY Revenue in Invasive Fungal Infection Business (2018-2023)
11.13.5 IMMY Recent Development
11.14 Beijing Jinshanchuan
11.14.1 Beijing Jinshanchuan Company Detail
11.14.2 Beijing Jinshanchuan Business Overview
11.14.3 Beijing Jinshanchuan Invasive Fungal Infection Introduction
11.14.4 Beijing Jinshanchuan Revenue in Invasive Fungal Infection Business (2018-2023)
11.14.5 Beijing Jinshanchuan Recent Development
11.15 Danna Biological
11.15.1 Danna Biological Company Detail
11.15.2 Danna Biological Business Overview
11.15.3 Danna Biological Invasive Fungal Infection Introduction
11.15.4 Danna Biological Revenue in Invasive Fungal Infection Business (2018-2023)
11.15.5 Danna Biological Recent Development
11.16 Zhanjiang A and C Biological
11.16.1 Zhanjiang A and C Biological Company Detail
11.16.2 Zhanjiang A and C Biological Business Overview
11.16.3 Zhanjiang A and C Biological Invasive Fungal Infection Introduction
11.16.4 Zhanjiang A and C Biological Revenue in Invasive Fungal Infection Business (2018-2023)
11.16.5 Zhanjiang A and C Biological Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Invasive Fungal Infection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Invasive Fungal Infection Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Yeast-like Fungi
1.3.3 Filamentous Fungi
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Invasive Fungal Infection Market Perspective (2018-2029)
2.2 Invasive Fungal Infection Growth Trends by Region
2.2.1 Global Invasive Fungal Infection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Invasive Fungal Infection Historic Market Size by Region (2018-2023)
2.2.3 Invasive Fungal Infection Forecasted Market Size by Region (2024-2029)
2.3 Invasive Fungal Infection Market Dynamics
2.3.1 Invasive Fungal Infection Industry Trends
2.3.2 Invasive Fungal Infection Market Drivers
2.3.3 Invasive Fungal Infection Market Challenges
2.3.4 Invasive Fungal Infection Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Invasive Fungal Infection Players by Revenue
3.1.1 Global Top Invasive Fungal Infection Players by Revenue (2018-2023)
3.1.2 Global Invasive Fungal Infection Revenue Market Share by Players (2018-2023)
3.2 Global Invasive Fungal Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Invasive Fungal Infection Revenue
3.4 Global Invasive Fungal Infection Market Concentration Ratio
3.4.1 Global Invasive Fungal Infection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Invasive Fungal Infection Revenue in 2022
3.5 Invasive Fungal Infection Key Players Head office and Area Served
3.6 Key Players Invasive Fungal Infection Product Solution and Service
3.7 Date of Enter into Invasive Fungal Infection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 INVASIVE FUNGAL INFECTION BREAKDOWN DATA BY TYPE
4.1 Global Invasive Fungal Infection Historic Market Size by Type (2018-2023)
4.2 Global Invasive Fungal Infection Forecasted Market Size by Type (2024-2029)
5 INVASIVE FUNGAL INFECTION BREAKDOWN DATA BY APPLICATION
5.1 Global Invasive Fungal Infection Historic Market Size by Application (2018-2023)
5.2 Global Invasive Fungal Infection Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Invasive Fungal Infection Market Size (2018-2029)
6.2 North America Invasive Fungal Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Invasive Fungal Infection Market Size by Country (2018-2023)
6.4 North America Invasive Fungal Infection Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Invasive Fungal Infection Market Size (2018-2029)
7.2 Europe Invasive Fungal Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Invasive Fungal Infection Market Size by Country (2018-2023)
7.4 Europe Invasive Fungal Infection Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Invasive Fungal Infection Market Size (2018-2029)
8.2 Asia-Pacific Invasive Fungal Infection Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Invasive Fungal Infection Market Size by Region (2018-2023)
8.4 Asia-Pacific Invasive Fungal Infection Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Invasive Fungal Infection Market Size (2018-2029)
9.2 Latin America Invasive Fungal Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Invasive Fungal Infection Market Size by Country (2018-2023)
9.4 Latin America Invasive Fungal Infection Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Invasive Fungal Infection Market Size (2018-2029)
10.2 Middle East & Africa Invasive Fungal Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Invasive Fungal Infection Market Size by Country (2018-2023)
10.4 Middle East & Africa Invasive Fungal Infection Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Cidara Therapeutics
11.1.1 Cidara Therapeutics Company Detail
11.1.2 Cidara Therapeutics Business Overview
11.1.3 Cidara Therapeutics Invasive Fungal Infection Introduction
11.1.4 Cidara Therapeutics Revenue in Invasive Fungal Infection Business (2018-2023)
11.1.5 Cidara Therapeutics Recent Development
11.2 Basilea Pharmaceutica
11.2.1 Basilea Pharmaceutica Company Detail
11.2.2 Basilea Pharmaceutica Business Overview
11.2.3 Basilea Pharmaceutica Invasive Fungal Infection Introduction
11.2.4 Basilea Pharmaceutica Revenue in Invasive Fungal Infection Business (2018-2023)
11.2.5 Basilea Pharmaceutica Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Invasive Fungal Infection Introduction
11.3.4 Pfizer Revenue in Invasive Fungal Infection Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Invasive Fungal Infection Introduction
11.4.4 GlaxoSmithKline Revenue in Invasive Fungal Infection Business (2018-2023)
11.4.5 GlaxoSmithKline Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Invasive Fungal Infection Introduction
11.5.4 Bayer Revenue in Invasive Fungal Infection Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Invasive Fungal Infection Introduction
11.6.4 Abbott Revenue in Invasive Fungal Infection Business (2018-2023)
11.6.5 Abbott Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Invasive Fungal Infection Introduction
11.7.4 Merck Revenue in Invasive Fungal Infection Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Astellas Pharma
11.8.1 Astellas Pharma Company Detail
11.8.2 Astellas Pharma Business Overview
11.8.3 Astellas Pharma Invasive Fungal Infection Introduction
11.8.4 Astellas Pharma Revenue in Invasive Fungal Infection Business (2018-2023)
11.8.5 Astellas Pharma Recent Development
11.9 F2G
11.9.1 F2G Company Detail
11.9.2 F2G Business Overview
11.9.3 F2G Invasive Fungal Infection Introduction
11.9.4 F2G Revenue in Invasive Fungal Infection Business (2018-2023)
11.9.5 F2G Recent Development
11.10 Scynexis
11.10.1 Scynexis Company Detail
11.10.2 Scynexis Business Overview
11.10.3 Scynexis Invasive Fungal Infection Introduction
11.10.4 Scynexis Revenue in Invasive Fungal Infection Business (2018-2023)
11.10.5 Scynexis Recent Development
11.11 Associates of Cape Cod
11.11.1 Associates of Cape Cod Company Detail
11.11.2 Associates of Cape Cod Business Overview
11.11.3 Associates of Cape Cod Invasive Fungal Infection Introduction
11.11.4 Associates of Cape Cod Revenue in Invasive Fungal Infection Business (2018-2023)
11.11.5 Associates of Cape Cod Recent Development
11.12 BioRad
11.12.1 BioRad Company Detail
11.12.2 BioRad Business Overview
11.12.3 BioRad Invasive Fungal Infection Introduction
11.12.4 BioRad Revenue in Invasive Fungal Infection Business (2018-2023)
11.12.5 BioRad Recent Development
11.13 IMMY
11.13.1 IMMY Company Detail
11.13.2 IMMY Business Overview
11.13.3 IMMY Invasive Fungal Infection Introduction
11.13.4 IMMY Revenue in Invasive Fungal Infection Business (2018-2023)
11.13.5 IMMY Recent Development
11.14 Beijing Jinshanchuan
11.14.1 Beijing Jinshanchuan Company Detail
11.14.2 Beijing Jinshanchuan Business Overview
11.14.3 Beijing Jinshanchuan Invasive Fungal Infection Introduction
11.14.4 Beijing Jinshanchuan Revenue in Invasive Fungal Infection Business (2018-2023)
11.14.5 Beijing Jinshanchuan Recent Development
11.15 Danna Biological
11.15.1 Danna Biological Company Detail
11.15.2 Danna Biological Business Overview
11.15.3 Danna Biological Invasive Fungal Infection Introduction
11.15.4 Danna Biological Revenue in Invasive Fungal Infection Business (2018-2023)
11.15.5 Danna Biological Recent Development
11.16 Zhanjiang A and C Biological
11.16.1 Zhanjiang A and C Biological Company Detail
11.16.2 Zhanjiang A and C Biological Business Overview
11.16.3 Zhanjiang A and C Biological Invasive Fungal Infection Introduction
11.16.4 Zhanjiang A and C Biological Revenue in Invasive Fungal Infection Business (2018-2023)
11.16.5 Zhanjiang A and C Biological Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Invasive Fungal Infection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Invasive Fungal Infection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Invasive Fungal Infection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Invasive Fungal Infection Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Invasive Fungal Infection Market Share by Region (2018-2023)
Table 8. Global Invasive Fungal Infection Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Invasive Fungal Infection Market Share by Region (2024-2029)
Table 10. Invasive Fungal Infection Market Trends
Table 11. Invasive Fungal Infection Market Drivers
Table 12. Invasive Fungal Infection Market Challenges
Table 13. Invasive Fungal Infection Market Restraints
Table 14. Global Invasive Fungal Infection Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Invasive Fungal Infection Market Share by Players (2018-2023)
Table 16. Global Top Invasive Fungal Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Fungal Infection as of 2022)
Table 17. Ranking of Global Top Invasive Fungal Infection Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Invasive Fungal Infection Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Invasive Fungal Infection Product Solution and Service
Table 21. Date of Enter into Invasive Fungal Infection Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Invasive Fungal Infection Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Invasive Fungal Infection Revenue Market Share by Type (2018-2023)
Table 25. Global Invasive Fungal Infection Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Invasive Fungal Infection Revenue Market Share by Type (2024-2029)
Table 27. Global Invasive Fungal Infection Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Invasive Fungal Infection Revenue Market Share by Application (2018-2023)
Table 29. Global Invasive Fungal Infection Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Invasive Fungal Infection Revenue Market Share by Application (2024-2029)
Table 31. North America Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Invasive Fungal Infection Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Invasive Fungal Infection Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Invasive Fungal Infection Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Invasive Fungal Infection Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Invasive Fungal Infection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Invasive Fungal Infection Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Invasive Fungal Infection Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Invasive Fungal Infection Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Invasive Fungal Infection Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Invasive Fungal Infection Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Invasive Fungal Infection Market Size by Country (2024-2029) & (US$ Million)
Table 46. Cidara Therapeutics Company Detail
Table 47. Cidara Therapeutics Business Overview
Table 48. Cidara Therapeutics Invasive Fungal Infection Product
Table 49. Cidara Therapeutics Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 50. Cidara Therapeutics Recent Development
Table 51. Basilea Pharmaceutica Company Detail
Table 52. Basilea Pharmaceutica Business Overview
Table 53. Basilea Pharmaceutica Invasive Fungal Infection Product
Table 54. Basilea Pharmaceutica Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 55. Basilea Pharmaceutica Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Invasive Fungal Infection Product
Table 59. Pfizer Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. GlaxoSmithKline Company Detail
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Invasive Fungal Infection Product
Table 64. GlaxoSmithKline Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Bayer Company Detail
Table 67. Bayer Business Overview
Table 68. Bayer Invasive Fungal Infection Product
Table 69. Bayer Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Abbott Company Detail
Table 72. Abbott Business Overview
Table 73. Abbott Invasive Fungal Infection Product
Table 74. Abbott Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Merck Company Detail
Table 77. Merck Business Overview
Table 78. Merck Invasive Fungal Infection Product
Table 79. Merck Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Astellas Pharma Company Detail
Table 82. Astellas Pharma Business Overview
Table 83. Astellas Pharma Invasive Fungal Infection Product
Table 84. Astellas Pharma Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 85. Astellas Pharma Recent Development
Table 86. F2G Company Detail
Table 87. F2G Business Overview
Table 88. F2G Invasive Fungal Infection Product
Table 89. F2G Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 90. F2G Recent Development
Table 91. Scynexis Company Detail
Table 92. Scynexis Business Overview
Table 93. Scynexis Invasive Fungal Infection Product
Table 94. Scynexis Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 95. Scynexis Recent Development
Table 96. Associates of Cape Cod Company Detail
Table 97. Associates of Cape Cod Business Overview
Table 98. Associates of Cape Cod Invasive Fungal Infection Product
Table 99. Associates of Cape Cod Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 100. Associates of Cape Cod Recent Development
Table 101. BioRad Company Detail
Table 102. BioRad Business Overview
Table 103. BioRad Invasive Fungal Infection Product
Table 104. BioRad Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 105. BioRad Recent Development
Table 106. IMMY Company Detail
Table 107. IMMY Business Overview
Table 108. IMMY Invasive Fungal Infection Product
Table 109. IMMY Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 110. IMMY Recent Development
Table 111. Beijing Jinshanchuan Company Detail
Table 112. Beijing Jinshanchuan Business Overview
Table 113. Beijing Jinshanchuan Invasive Fungal Infection Product
Table 114. Beijing Jinshanchuan Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 115. Beijing Jinshanchuan Recent Development
Table 116. Danna Biological Company Detail
Table 117. Danna Biological Business Overview
Table 118. Danna Biological Invasive Fungal Infection Product
Table 119. Danna Biological Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 120. Danna Biological Recent Development
Table 121. Zhanjiang A and C Biological Company Detail
Table 122. Zhanjiang A and C Biological Business Overview
Table 123. Zhanjiang A and C Biological Invasive Fungal Infection Product
Table 124. Zhanjiang A and C Biological Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 125. Zhanjiang A and C Biological Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 1. Global Invasive Fungal Infection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Invasive Fungal Infection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Invasive Fungal Infection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Invasive Fungal Infection Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Invasive Fungal Infection Market Share by Region (2018-2023)
Table 8. Global Invasive Fungal Infection Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Invasive Fungal Infection Market Share by Region (2024-2029)
Table 10. Invasive Fungal Infection Market Trends
Table 11. Invasive Fungal Infection Market Drivers
Table 12. Invasive Fungal Infection Market Challenges
Table 13. Invasive Fungal Infection Market Restraints
Table 14. Global Invasive Fungal Infection Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Invasive Fungal Infection Market Share by Players (2018-2023)
Table 16. Global Top Invasive Fungal Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Fungal Infection as of 2022)
Table 17. Ranking of Global Top Invasive Fungal Infection Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Invasive Fungal Infection Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Invasive Fungal Infection Product Solution and Service
Table 21. Date of Enter into Invasive Fungal Infection Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Invasive Fungal Infection Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Invasive Fungal Infection Revenue Market Share by Type (2018-2023)
Table 25. Global Invasive Fungal Infection Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Invasive Fungal Infection Revenue Market Share by Type (2024-2029)
Table 27. Global Invasive Fungal Infection Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Invasive Fungal Infection Revenue Market Share by Application (2018-2023)
Table 29. Global Invasive Fungal Infection Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Invasive Fungal Infection Revenue Market Share by Application (2024-2029)
Table 31. North America Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Invasive Fungal Infection Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Invasive Fungal Infection Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Invasive Fungal Infection Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Invasive Fungal Infection Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Invasive Fungal Infection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Invasive Fungal Infection Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Invasive Fungal Infection Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Invasive Fungal Infection Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Invasive Fungal Infection Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Invasive Fungal Infection Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Invasive Fungal Infection Market Size by Country (2024-2029) & (US$ Million)
Table 46. Cidara Therapeutics Company Detail
Table 47. Cidara Therapeutics Business Overview
Table 48. Cidara Therapeutics Invasive Fungal Infection Product
Table 49. Cidara Therapeutics Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 50. Cidara Therapeutics Recent Development
Table 51. Basilea Pharmaceutica Company Detail
Table 52. Basilea Pharmaceutica Business Overview
Table 53. Basilea Pharmaceutica Invasive Fungal Infection Product
Table 54. Basilea Pharmaceutica Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 55. Basilea Pharmaceutica Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Invasive Fungal Infection Product
Table 59. Pfizer Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. GlaxoSmithKline Company Detail
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Invasive Fungal Infection Product
Table 64. GlaxoSmithKline Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Bayer Company Detail
Table 67. Bayer Business Overview
Table 68. Bayer Invasive Fungal Infection Product
Table 69. Bayer Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Abbott Company Detail
Table 72. Abbott Business Overview
Table 73. Abbott Invasive Fungal Infection Product
Table 74. Abbott Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Merck Company Detail
Table 77. Merck Business Overview
Table 78. Merck Invasive Fungal Infection Product
Table 79. Merck Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Astellas Pharma Company Detail
Table 82. Astellas Pharma Business Overview
Table 83. Astellas Pharma Invasive Fungal Infection Product
Table 84. Astellas Pharma Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 85. Astellas Pharma Recent Development
Table 86. F2G Company Detail
Table 87. F2G Business Overview
Table 88. F2G Invasive Fungal Infection Product
Table 89. F2G Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 90. F2G Recent Development
Table 91. Scynexis Company Detail
Table 92. Scynexis Business Overview
Table 93. Scynexis Invasive Fungal Infection Product
Table 94. Scynexis Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 95. Scynexis Recent Development
Table 96. Associates of Cape Cod Company Detail
Table 97. Associates of Cape Cod Business Overview
Table 98. Associates of Cape Cod Invasive Fungal Infection Product
Table 99. Associates of Cape Cod Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 100. Associates of Cape Cod Recent Development
Table 101. BioRad Company Detail
Table 102. BioRad Business Overview
Table 103. BioRad Invasive Fungal Infection Product
Table 104. BioRad Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 105. BioRad Recent Development
Table 106. IMMY Company Detail
Table 107. IMMY Business Overview
Table 108. IMMY Invasive Fungal Infection Product
Table 109. IMMY Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 110. IMMY Recent Development
Table 111. Beijing Jinshanchuan Company Detail
Table 112. Beijing Jinshanchuan Business Overview
Table 113. Beijing Jinshanchuan Invasive Fungal Infection Product
Table 114. Beijing Jinshanchuan Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 115. Beijing Jinshanchuan Recent Development
Table 116. Danna Biological Company Detail
Table 117. Danna Biological Business Overview
Table 118. Danna Biological Invasive Fungal Infection Product
Table 119. Danna Biological Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 120. Danna Biological Recent Development
Table 121. Zhanjiang A and C Biological Company Detail
Table 122. Zhanjiang A and C Biological Business Overview
Table 123. Zhanjiang A and C Biological Invasive Fungal Infection Product
Table 124. Zhanjiang A and C Biological Revenue in Invasive Fungal Infection Business (2018-2023) & (US$ Million)
Table 125. Zhanjiang A and C Biological Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Invasive Fungal Infection Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Invasive Fungal Infection Market Share by Type: 2022 VS 2029
Figure 3. Diagnosis Features
Figure 4. Treatment Features
Figure 5. Global Invasive Fungal Infection Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Invasive Fungal Infection Market Share by Application: 2022 VS 2029
Figure 7. Yeast-like Fungi Case Studies
Figure 8. Filamentous Fungi Case Studies
Figure 9. Other Case Studies
Figure 10. Invasive Fungal Infection Report Years Considered
Figure 11. Global Invasive Fungal Infection Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Invasive Fungal Infection Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Invasive Fungal Infection Market Share by Region: 2022 VS 2029
Figure 14. Global Invasive Fungal Infection Market Share by Players in 2022
Figure 15. Global Top Invasive Fungal Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Fungal Infection as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Invasive Fungal Infection Revenue in 2022
Figure 17. North America Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Invasive Fungal Infection Market Share by Country (2018-2029)
Figure 19. United States Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Invasive Fungal Infection Market Share by Country (2018-2029)
Figure 23. Germany Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Invasive Fungal Infection Market Share by Region (2018-2029)
Figure 31. China Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Invasive Fungal Infection Market Share by Country (2018-2029)
Figure 39. Mexico Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Invasive Fungal Infection Market Share by Country (2018-2029)
Figure 43. Turkey Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Cidara Therapeutics Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 46. Basilea Pharmaceutica Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 49. Bayer Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 50. Abbott Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 52. Astellas Pharma Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 53. F2G Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 54. Scynexis Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 55. Associates of Cape Cod Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 56. BioRad Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 57. IMMY Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 58. Beijing Jinshanchuan Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 59. Danna Biological Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 60. Zhanjiang A and C Biological Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Figure 1. Global Invasive Fungal Infection Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Invasive Fungal Infection Market Share by Type: 2022 VS 2029
Figure 3. Diagnosis Features
Figure 4. Treatment Features
Figure 5. Global Invasive Fungal Infection Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Invasive Fungal Infection Market Share by Application: 2022 VS 2029
Figure 7. Yeast-like Fungi Case Studies
Figure 8. Filamentous Fungi Case Studies
Figure 9. Other Case Studies
Figure 10. Invasive Fungal Infection Report Years Considered
Figure 11. Global Invasive Fungal Infection Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Invasive Fungal Infection Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Invasive Fungal Infection Market Share by Region: 2022 VS 2029
Figure 14. Global Invasive Fungal Infection Market Share by Players in 2022
Figure 15. Global Top Invasive Fungal Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Fungal Infection as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Invasive Fungal Infection Revenue in 2022
Figure 17. North America Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Invasive Fungal Infection Market Share by Country (2018-2029)
Figure 19. United States Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Invasive Fungal Infection Market Share by Country (2018-2029)
Figure 23. Germany Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Invasive Fungal Infection Market Share by Region (2018-2029)
Figure 31. China Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Invasive Fungal Infection Market Share by Country (2018-2029)
Figure 39. Mexico Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Invasive Fungal Infection Market Share by Country (2018-2029)
Figure 43. Turkey Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Invasive Fungal Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Cidara Therapeutics Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 46. Basilea Pharmaceutica Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 49. Bayer Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 50. Abbott Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 52. Astellas Pharma Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 53. F2G Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 54. Scynexis Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 55. Associates of Cape Cod Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 56. BioRad Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 57. IMMY Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 58. Beijing Jinshanchuan Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 59. Danna Biological Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 60. Zhanjiang A and C Biological Revenue Growth Rate in Invasive Fungal Infection Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
